So many companies get a price pop on good data, th
Post# of 148092
Quote:
So many companies get a price pop on good data, then a slow or fast slide back down to baseline. It's a slog, even though Leronlimab is safe and even though we're trying to help people.
Do you believe $.11-.12 is a fair and reasonable baseline?
If you answer “no” then you should agree with Figgs’ sentiment.